ArticleCellular oncology (Dordrecht, Netherlands)2020

Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer.

Sandro Mascena Gomes-Filho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.